Longitudinal body-weight measurements for a cohort of neonates over roughly
the first week of life, used as the second case study (neonatal weight
progression) in Rohleff et al. (2025) on VAE-based nonlinear mixed-effects
modeling. There is no dosing; body weight follows a turnover (zero-order
production, first-order elimination) growth model whose initial weight is an
estimated parameter, so every record is an observation (EVID = 0).
Format
A data frame with 1120 rows by 9 columns
- ID
Subject ID (189 neonates)
- TIME
Time since birth (days)
- DV
Dependent Variable, body weight (g)
- EVID
rxode2/nlmixr2 event ID (0 = observation; no dosing)
- Sex
Sex, 0/1
- DelM
Delivery mode, 0/1
- GA
Gestational age at birth (weeks)
- Mage
Maternal age (years)
- Para2
Parity indicator, 0/1
See also
Other nlmixr2 datasets:
Bolus_1CPT,
Bolus_1CPTMM,
Bolus_2CPT,
Bolus_2CPTMM,
Infusion_1CPT,
Infusion_1CPTMM,
Infusion_2CPT,
Infusion_2CPTMM,
Oral_1CPT,
Oral_1CPTMM,
Oral_2CPT,
Oral_2CPTMM,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim